Steward Partners Investment Advisory LLC lessened its stake in shares of DocuSign, Inc. (NASDAQ:DOCU – Free Report) by 71.6% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 9,510 shares of the company’s stock after selling 23,963 shares during the quarter. Steward Partners Investment Advisory LLC’s holdings in DocuSign were worth $855,000 at the end of the most recent reporting period.
Other hedge funds have also added to or reduced their stakes in the company. State Street Corp grew its holdings in shares of DocuSign by 2.3% during the third quarter. State Street Corp now owns 5,372,939 shares of the company’s stock worth $333,604,000 after purchasing an additional 120,743 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of DocuSign by 1.6% during the third quarter. Geode Capital Management LLC now owns 3,483,184 shares of the company’s stock worth $215,789,000 after purchasing an additional 53,554 shares in the last quarter. Thrivent Financial for Lutherans grew its holdings in shares of DocuSign by 5.2% during the third quarter. Thrivent Financial for Lutherans now owns 2,277,312 shares of the company’s stock worth $141,398,000 after purchasing an additional 112,919 shares in the last quarter. FMR LLC grew its holdings in shares of DocuSign by 16.8% during the third quarter. FMR LLC now owns 2,192,885 shares of the company’s stock worth $136,156,000 after purchasing an additional 315,073 shares in the last quarter. Finally, Bank of New York Mellon Corp grew its holdings in shares of DocuSign by 61.5% during the fourth quarter. Bank of New York Mellon Corp now owns 1,673,612 shares of the company’s stock worth $150,525,000 after purchasing an additional 637,505 shares in the last quarter. Hedge funds and other institutional investors own 77.64% of the company’s stock.
DocuSign Stock Performance
Shares of DOCU stock opened at $77.86 on Tuesday. DocuSign, Inc. has a fifty-two week low of $48.70 and a fifty-two week high of $107.86. The stock has a 50 day moving average price of $88.78 and a two-hundred day moving average price of $78.90. The company has a market capitalization of $15.73 billion, a P/E ratio of 16.05, a PEG ratio of 6.94 and a beta of 1.02.
Wall Street Analysts Forecast Growth
Read Our Latest Research Report on DocuSign
Insider Buying and Selling at DocuSign
In related news, Director Teresa Briggs sold 534 shares of the company’s stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $94.60, for a total transaction of $50,516.40. Following the completion of the transaction, the director now owns 7,736 shares in the company, valued at $731,825.60. This represents a 6.46 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Allan C. Thygesen sold 40,000 shares of the company’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $90.04, for a total value of $3,601,600.00. Following the transaction, the chief executive officer now owns 156,050 shares of the company’s stock, valued at approximately $14,050,742. This represents a 20.40 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 104,422 shares of company stock worth $9,665,394. 1.66% of the stock is currently owned by insiders.
DocuSign Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Further Reading
- Five stocks we like better than DocuSign
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- How to Protect Your Portfolio When Inflation Is Rising
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- There Are Different Types of Stock To Invest In
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.